Inovio Pharmaceuticals
Inovio Pharmaceuticals
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | Blood-Borne Infections, Chronic Disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Flaviviridae infectious disease, Hepatitis, Chronic, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, adenocarcinoma, carcinoma, epithelial neoplasm, hepatitis, hepatitis C virus infection, hepatocellular carcinoma, infectious disease, liver disorder, neoplasm, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 1 | 2026-09-11 | NCT02772003 | |
| INO 5401 Vaccination in BRCA1/2 Mutation Carriers | BRCA1/2 Mutation | Active, not recruiting | Phase 1 | 2026-08-14 | NCT04367675 | |
| INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-04 | NCT03491683 |